Summary
Cerebrospinal fluid (CSF) concentration of β-endorphin (β- Ep), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) was measured in 15 patients with dementia of the Alzheimer type (DAT) and in 16 patients suspected of having Binswanger’s disease (BD) by MRI, which sometimes resembles DAT clinically. These were classified into three stages according to severity of dementia, Stage 1 (mild dementia)-Stage 3 (severe dementia). CSF levels of HVA decreased significantly in severe dementia, but the level of 5-HIAA did not correlate with dementia severity in both dementia groups. β-Ep levels did not differ significantly between any stages of DAT, and among controls. β-Ep levels, however, in BD Stage 1 (27.5 ± 5.9 pg/ml) were significantly higher (p < 0.05), but level in Stage 3 (6.7 ± 2.0) was significantly lower (p < 0.001) than in the controls (19.2 ± 4.5). These results suggest that CSF β-Ep may depend on the cause of dementia rather than severity of dementia, and could possibly distinguish the closely resembling BD from true DAT.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Almay BG, Johansson F, von Knorring L, Terenius L, Wahlström A (1978) Endorphins in chronic pain. 1. Differences in CSF endorphin levels between organic and psychogenic pain syndromes. Pain 5:153–162
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn (revised). Washington, DC
Bareggi SR, Franceschi M, Bonini L, Zecca L, Smirne S (1982) Decreased CSF concentrations of homovanillic acid and y-aminobutyric acid in Alzheimer’s disease: age or disease-related modifications? Arch Neurol 39: 709–712
Biemond A (1970) On Binswanger’s subcortical arteriosclerotic encephalopathy and possibility of its clinical recognition. Psychiat Neurol Neurochir 73:413–417
Binswanger O (1894) Die Abgrenzung der allgemeinen progressiven Paralyse. Berl Klin Wochenschr 31:1103–1105, 1137–1139, 1180–1186
Bourre JM, Chanez C, Dumont O, Flexor MA (1982) Alteration of 5′-nucleotidase and Na+, K+-ATPase in central and peripheral nervous tissue from dysmyelinating mutants (jimpy, quaking, Trembler, shiverer, and mld). Comparison with CNPase in the developing sciatic nerve from Trembler. J Neurochem 38: 643–649
Brismar T (1983) Neuropathy-functional abnormalities in the BB rat. Metabolism 32 [Suppl 1]:112–117
Bulat M (1977) On the cerebral origin of 5-hydroxyindoleacetic acid in the lumbar cerebrospinal fluid. Brain Res 122:388–391
Bulat M, Lackovic Z, Jakupcevic M (1974) 5-Hydroxyindoleacetic acid in the lumbar fluid: a specific indicator of spinal cord injury. Science 185:527–528
Caplan LR, Schoene WC (1978) Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger’s disease). Neurology 28:1206–1215
Chiba T (1988) Studies of β-endorphin and methionin-enkephalin in cerebral vascular disease. Its evaluation and clinical significance of periodic changes. Nippon Ika Daigaku Zasshi 55:46–53
Clement-Jones V, McLoughlin L, Tomlin S, Besser GM, Rees LH, Wen HL (1980) Increased β-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet ii: 946–949
Erkinjuntti T, Sipponen JT, Iivanainen M, Ketonen L, Sulkava R, Sepponen RE (1984) Cerebral NMR and CT imaging in dementia. J Comput Assist Tomogr 8:614–618
Facchinetti F, Nappi G, Petraglia F, Martignoni E, Sinforiani E, Genazzani AR (1984) Central ACTH deficit in degenerative and vascular dementia. Life Sci 35 :1691–1697
Facchinetti F, Petraglia G, Nappi G, Martignoni E, Antoni G, Parrini D, Genazzani AR (1983) Different patterns of central and peripheral βEP, βLPH and ACTH throughout life. Peptides 4: 469–474
Folstein MF, Folstein SE, McHugh PR (1975)“Mini-Mental State” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Frances B, Moisand C, Meunier J-C (1985) Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at µ- and k-opioid receptor sites in rabbit and Guineapig cerebellum membranes. Eur J Pharmacol 117:223–232
Furui T, Satoh K, Asano Y, Shimosawa S, Hasuo M, Yaksh TL (1984) Increase of β-endorphin levels in cerebrospinal fluid but not in plasma in patients with cerebral infarction. J Neurosurg 61: 748–751
George AE, de Leon MJ, Kalnin A, Rosner L, Goodgold A, Chase N (1986) Leukoencephalopathy in normal and pathologic aging. 2. MRI of brain lucencies. AJNR 7:567–570
Grandison L, Guidotti A (1977) Stimulation of food intake by muscimol and beta endorphin. Neuropharmacology 16:533–536
Hachinski VC, Iliff LD, Zilhka M, Du Boulay GH, McAllister VL, Marshall J, Ross Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632–637
Izquierdo I, Netto CA (1985) The brain β-endorphin system and behavior: the modulation of consecutively and simultaneously processed memories. Behav Neural Biol 44:249–265
Jellinger K, Neumayer E (1964) Progressive subcorticale vasculäre Encephalopathie Binswanger. Eine klinisch-neuropathologische Studie. Arch Psychiatr Nervenkr 205:523–554
Janota I (1981) Dementia, deep white matter damage and hypertension: ‘Binswanger’s disease’. Psychol Med 11: 39–48
Kaiya H, Tanaka T, Takeuchi K, Morita K, Adachi S, Shirakawa H, Ueki H, Namba M (1983) Decreased level of β-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Life Sci 33:1039–1043
Kinkel WR, Jacobs L, Polachini I, Bates V, Heffner RR Jr (1985) Subcortical arteriosclerotic encephalopathy (Binswanger’s disease). Computed tomographic, nuclear magnetic resonance, and clinical correlations. Arch Neurol 42:951–959
McKhan G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–944
Nappi G, Facchinetti F, Bono G, Petraglia F, Sinforiani E, Genazzani AR (1986) CSF and plasma levels of pro-opiomelanocortin-related peptides in reversible ischemic attacks and strokes. J Neurol Neurosurg Psychiatry 49:17–21
Olszewski J (1965) Subcortical arteriosclerotic encephalopathy. Review of the literature on the so-called Binswanger’s disease and presentation of two cases. World Neurol 3:359–374
Raskind MA, Peskind ER, Lampe TH, Risse SC, Taborsky GJ Jr, Dorsa D (1986) Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and β-endorphin in Alzheimer’s disease. Arch Gen Psychiatry 43:382–388
Rezek DL, Morris JC, Fulling KH, Gado MH (1987) Periventricular white matter lucencies in senile dementia of Alzheimer type and in normal aging. Neurology 37:1365–1368
Rosenberg GA, Kornfeld M, Stovring J, Bicknell JM (1979) Subcortical arterisclerotic encephalopathy (Binswanger). Computerized tomography. Neurology 29:1102–1106
Soininen H, MacDonald E, Rekonnen M, Riekkinen PJ (1981) Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand 64:101–107
Steingart A, Hacinski VC, Lau C, Fox AJ, Fox H, Lee D, Inzitari D, Merskey H (1987) Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (Leuko-Araiosis). Arch Neurol 44:36–39
Sulkava R, Erkinjuntti T, Laatikainen T (1985) CSF β-endorphin and β-lipotropin in Alzheimer’s disease and multi-infarct dementia. Neurology 35:1057–1058
Todorov A, Go RC, Constantinidis J, Elston R (1975) Specificity of the clinical diagnosis of dementia. J Neurol Sci 26: 81–98
Tseng LF, Wei ET, Loh HH, Li CH (1980) β-Endorphin: central sites of analgesia, catalepsy and body temperature changes in rats. J Pharm Exp 214: 328–332
Wade JP, Mirsen TR, Hachinski VC, Fisman M, Lau C, Merskey H (1987) The clinical diagnosis of Alzheimer’s disease. Arch Neurol 44: 24–29
Wardlaw SL, Stark RI, Baxi L, Frantz AG (1979) Plasma β-endorphin and β-lipotropin in the human fetus at delivery: correlation with arterial pH and po 2. J Clin Endocrinol Metab 49: 888–891
Yasunari K, Kohno M, Kanayama Y, Kono Y, Amatsu K, Takeda T, Sato K, Kotsugi N (1988) Changes of plasma levels of β-endorphin-like immunoreactivity after acute clonidine administration in patients with essential hypertension. Horm Metabol Res 17:324–325
Zeumer H, Schonsky B, Sturm KW (1980) Predominant white matter involvement in subcortical arteriosclerotic encephalopathy (Binswanger disease). J Comput Assist Tomogr 4:14–19
Zimmerman RD, Flemming CA, Lee BCP, Saint-Louis LA, Deck MDF (1986) Periventricular hyperintensity as seen by magnetic resonance. Prevalence and significance. AJR 146:443–450
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag
About this paper
Cite this paper
Lee, S. et al. (1990). CSF β-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger’s disease in the elderly. In: Gottfries, C.G., Nakamura, S. (eds) Neurotransmitter and Dementia. Journal of Neural Transmission, vol 30. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3345-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-7091-3345-3_5
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82190-9
Online ISBN: 978-3-7091-3345-3
eBook Packages: Springer Book Archive